Omega Healthcare Investors (OHI), Pfizer (PFE), Gerdau S.A. (GGB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Omega Healthcare Investors (OHI)
130% sales growth and 5.63% return on equity
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities.
Omega Healthcare Investors's sales growth this year is anticipated to be 22.8% and 2.5% for next year.
Year-on-year quarterly revenue growth grew by 8.2%, now sitting on 913.12M for the twelve trailing months.
Volume
Today's last reported volume for Omega Healthcare Investors is 1140710 which is 42.09% below its average volume of 1969720.
Omega Healthcare Investors's sales growth for the next quarter is 130%. The company's growth estimates for the current quarter and the next is a negative 4.7% and 202.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.63%.
Volatility
Omega Healthcare Investors's last day, last week, and last month's current volatility was 0.85%, 0.69%, and 1.11%, respectively.
Omega Healthcare Investors's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.75% (day), 1.70% (last week), and 2.26% (last month), respectively.
Omega Healthcare Investors's Stock Yearly Top and Bottom Value
Omega Healthcare Investors's stock is valued at $36.67 at 23:22 EST, under its 52-week high of $39.31 and way higher than its 52-week low of $28.08.
Omega Healthcare Investors's Moving Average
Omega Healthcare Investors's value is under its 50-day moving average of $36.71 and below its 200-day moving average of $37.00.2. Pfizer (PFE)
62.5% sales growth and 14.03% return on equity
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide.
Pfizer's sales growth this year is anticipated to be 74.9% and a negative 15% for next year.
Year-on-year quarterly revenue growth grew by 44.6%, now sitting on 46.41B for the twelve trailing months.
Volume
Today's last reported volume for Pfizer is 16552000 which is 37.12% below its average volume of 26322700.
Pfizer's sales growth for the next quarter is 62.5%. The company's growth estimates for the ongoing quarter and the next is 25.6% and 44.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.03%.
Volatility
Pfizer's last day, last week, and last month's current volatility was 1.02%, 0.42%, and 0.86%, respectively.
Pfizer's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.33% (day), 1.08% (last week), and 1.41% (last month), respectively.
Pfizer's Stock Yearly Top and Bottom Value
Pfizer's stock is valued at $39.73 at 23:22 EST, under its 52-week high of $43.08 and way above its 52-week low of $31.40.
Pfizer's Moving Average
Pfizer's worth is higher than its 50-day moving average of $39.41 and above its 200-day moving average of $37.27.Previous days news about Pfizer(PFE)
According to Bloomberg Quint on Wednesday, 30 June, "Many of them twist and amplify arguments made by U.S. politicians and also Michael Yeadon, a former Pfizer Inc. scientist and a Covid-vaccine skeptic who's become an icon for anti-vaxxers."
According to Bloomberg Quint on Wednesday, 30 June, "The German company said in a statement late Wednesday that its vaccine was 48% effective at preventing disease of any severity, slightly higher than seen in a preliminary readout of the trial results but well behind the efficacy rates of more than 90% shown by Pfizer Inc. and Moderna Inc.'s mRNA shots."
According to Bloomberg Quint on Wednesday, 30 June, "In June, when President Joe Biden announced that the U.S. planned to buy 500 million doses of Pfizer's coronavirus vaccine to share internationally, Pfizer said it would work with Zipline to deliver doses to hard to reach areas."
3. Gerdau S.A. (GGB)
50.8% sales growth and 14.49% return on equity
Gerdau S.A. provides steel products and services in the United States and Canada.
Gerdau S.A.'s sales growth this year is anticipated to be 55.7% and a negative 7.6% for next year.
Year-on-year quarterly revenue growth grew by 77.1%, now sitting on 50.93B for the twelve trailing months.
Volume
Today's last reported volume for Gerdau S.A. is 7408230 which is 62.32% below its average volume of 19662100.
Gerdau S.A.'s sales growth for the next quarter is 50.8%. The company's growth estimates for the present quarter and the next is 1600% and 233.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.49%.
Volatility
Gerdau S.A.'s last day, last week, and last month's current volatility was 0.99%, 2.27%, and 2.65%, respectively.
Gerdau S.A.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.53% (day), 3.59% (last week), and 3.84% (last month), respectively.
Gerdau S.A.'s Stock Yearly Top and Bottom Value
Gerdau S.A.'s stock is valued at $5.82 at 23:22 EST, way under its 52-week high of $7.27 and way above its 52-week low of $2.93.
Gerdau S.A.'s Moving Average
Gerdau S.A.'s value is under its 50-day moving average of $6.23 and above its 200-day moving average of $5.42.4. EMCORE Corporation (EMKR)
27.2% sales growth and 6.73% return on equity
EMCORE Corporation, together with its subsidiaries, provides advanced mixed-signal optics products in the United States, Canada, Asia, Europe, and internationally.
EMCORE Corporation's sales growth this year is expected to be 41.3% and 13.3% for next year.
Year-on-year quarterly revenue growth grew by 61%, now sitting on 132.63M for the twelve trailing months.
Volume
Today's last reported volume for EMCORE Corporation is 818635 which is 26.54% above its average volume of 646945.
EMCORE Corporation's sales growth is a negative 0% for the ongoing quarter and 27.2% for the next. The company's growth estimates for the ongoing quarter and the next is 666.7% and 80%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.73%.
EMCORE Corporation's Stock Yearly Top and Bottom Value
EMCORE Corporation's stock is valued at $9.22 at 23:22 EST, way under its 52-week high of $10.87 and way higher than its 52-week low of $2.87.
EMCORE Corporation's Moving Average
EMCORE Corporation's value is under its 50-day moving average of $9.41 and way higher than its 200-day moving average of $6.86.5. Amazon (AMZN)
23.4% sales growth and 31.92% return on equity
Amazon.com, Inc. engages in the retail sale of consumer products and subscriptions in North America and internationally.
Amazon's sales growth this year is expected to be 27% and 18.5% for next year.
Year-on-year quarterly revenue growth grew by 43.8%, now sitting on 419.13B for the twelve trailing months.
Volume
Today's last reported volume for Amazon is 2891820 which is 16.48% below its average volume of 3462360.
Amazon's sales growth for the next quarter is 23.4%. The company's growth estimates for the present quarter and the next is 18.6% and 4.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.92%.
Volatility
Amazon's last day, last week, and last month's current volatility was 2.27%, 0.82%, and 0.93%, respectively.
Amazon's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.15% (day), 1.32% (last week), and 1.51% (last month), respectively.
Amazon's Stock Yearly Top and Bottom Value
Amazon's stock is valued at $3,510.98 at 23:22 EST, under its 52-week high of $3,554.00 and way higher than its 52-week low of $2,871.00.
Amazon's Moving Average
Amazon's worth is above its 50-day moving average of $3,323.28 and higher than its 200-day moving average of $3,247.45.Previous days news about Amazon(AMZN)
According to GlobeNewsWire on Wednesday, 30 June, "It also includes seamless access to QPUs via Amazon Braket, including D-Wave, IonQ, and Rigetti."
6. Tetra Tech (TTEK)
10.5% sales growth and 17.94% return on equity
Tetra Tech, Inc. provides consulting and engineering services worldwide.
Tetra Tech's sales growth this year is anticipated to be 6.1% and 5.7% for next year.
Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 2.36B for the twelve trailing months.
Volume
Today's last reported volume for Tetra Tech is 202442 which is 32.12% below its average volume of 298233.
Tetra Tech's sales growth is a negative 0% for the present quarter and 10.5% for the next. The company's growth estimates for the current quarter and the next is 12.8% and 8.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.94%.
Volatility
Tetra Tech's last day, last week, and last month's current volatility was 0.12%, 0.62%, and 1.21%, respectively.
Tetra Tech's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.52% (day), 2.14% (last week), and 2.69% (last month), respectively.
Tetra Tech's Stock Yearly Top and Bottom Value
Tetra Tech's stock is valued at $124.13 at 23:22 EST, way under its 52-week high of $144.77 and way above its 52-week low of $74.96.